Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interstitial Lung Diseases and the Impact of Gender.
Karampitsakos T, Papaioannou O, Katsaras M, Sampsonas F, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Clin Chest Med. 2021 Sep;42(3):531-541. doi: 10.1016/j.ccm.2021.04.011. Clin Chest Med. 2021. PMID: 34353457 Review.
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis.
Karampitsakos T, Torrisi S, Antoniou K, Manali E, Korbila I, Papaioannou O, Sampsonas F, Katsaras M, Vasarmidi E, Papakosta D, Domvri K, Fouka E, Organtzis I, Daniil Z, Dimeas I, Kirgou P, Gourgoulianis KI, Papanikolaou IC, Markopoulou K, Kounti G, Tsapakidou E, Papadopoulou E, Tatsis K, Gogali A, Kostikas K, Tzilas V, Chrysikos S, Papiris S, Bouros D, Kreuter M, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Respir Res. 2021 May 5;22(1):140. doi: 10.1186/s12931-021-01725-9. Respir Res. 2021. PMID: 33952261 Free PMC article.
Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model.
Karampitsakos T, Kalogeropoulou C, Tzilas V, Papaioannou O, Kazantzi A, Koukaki E, Katsaras M, Bouros E, Tsiri P, Tsirikos G, Zarkadi E, Ntoulias N, Sotiropoulou V, Efthymiou P, Chrysikos S, Malakounidou E, Sampsonas F, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Respiration. 2022;101(3):262-271. doi: 10.1159/000519215. Epub 2021 Sep 30. Respiration. 2022. PMID: 34592744
Infliximab-induced interstitial lung disease.
Karampitsakos T, Papaioannou O, Sampsonas F, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. BMJ Case Rep. 2021 Oct 13;14(10):e245726. doi: 10.1136/bcr-2021-245726. BMJ Case Rep. 2021. PMID: 34645638 Free PMC article.
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study.
Karampitsakos T, Malakounidou E, Papaioannou O, Dimakopoulou V, Zarkadi E, Katsaras M, Tsiri P, Tsirikos G, Georgiopoulou V, Oikonomou I, Davoulos C, Velissaris D, Sampsonas F, Marangos M, Akinosoglou K, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Respir Res. 2021 Dec 22;22(1):317. doi: 10.1186/s12931-021-01914-6. Respir Res. 2021. PMID: 34937570 Free PMC article.
High-flow versus conventional nasal cannula oxygen supplementation therapy and risk of hypoxia in gastrointestinal endoscopies: a systematic review and meta-analysis.
Doulberis M, Sampsonas F, Papaefthymiou A, Karamouzos V, Lagadinou M, Karampitsakos T, Stratakos G, Kuntzen T, Tzouvelekis A. Doulberis M, et al. Among authors: sampsonas f. Expert Rev Respir Med. 2022 Mar;16(3):323-332. doi: 10.1080/17476348.2022.2042256. Epub 2022 Feb 22. Expert Rev Respir Med. 2022. PMID: 35157538
71 results